[{"Assets_0_Q3_USD":720590000.0,"CommonStockSharesOutstanding_0_Q3_shares":55189370.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":53301000.0,"NetIncomeLoss_1_Q3_USD":138423000.0,"NetIncomeLoss_3_Q3_USD":36316000.0,"StockholdersEquity_0_Q3_USD":591878000.0,"EarningsPerShareBasic_1_Q3_USD":2.52,"EarningsPerShareBasic_3_Q3_USD":0.68,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":54829057.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":53380123.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20191028"}]